Patrick McConville, Ph.D., is chief operating officer, chief scientific officer, and a co-founder of
Molecular Imaging Inc., the only contract research organization (CRO) dedicated to in vivo preclinical imaging.
Ideal Companies: Abbott Vascular Devices, Abbott Laboratories,
Inc., Advanced Neuromodulation Systems,
Inc. (ANS), Advanced Sterilization Products (ASP), American Medical Systems,
Inc. (AMS), Armstrong Healthcare Limited, Bausch & Lomb, BOSS Instruments, Ltd., Cardiac Science, CardioGenesis Corporation, Cook Incorporated, CTI
Molecular Imaging,
Inc., Davol,
Inc., Dräger Medical
Inc., Endocare,
Inc., ev3, Fischer
Imaging, GE Medical Systems, Hitachi Medical Systems America, Integrated Surgical Systems,
Inc., Johnson & Johnson, Kinetic Concepts,
Inc., Masimo Corporation, Ophthalmic
Imaging Systems, Philips Medical Systems, Proxima Therapeutics,
Inc., QRS Diagnostic, Siemens Medical Solutions, Smith & Nephew Orthopaedics, Smiths Medical, Stryker Corporation, Toshiba Medical, Valleylab, ZEVEX International,
Inc..